Pricing Log in Create free account

Pharvaris N.V. (PHVS) vs Zai Lab Limited Unsponsored ADR (ZLAB)

Pharvaris N.V. and Zai Lab Limited Unsponsored ADR are both Biotechnology companies. Zai Lab Limited Unsponsored ADR is the larger, with a market value of $2.6B against $2.3B — 1.1× the size. Pharvaris N.V. has the higher net margin (0.00% vs −44.9%) and the higher return on invested capital (0.00% vs −21.3%). Across the 13 metrics below, Pharvaris N.V. leads on 7 and Zai Lab Limited Unsponsored ADR on 6.

Valuation

Metric PHVS ZLAB Biotechnology median
P/E n/m n/m 10.26
P/S n/m 5.74 9.18
P/B 6.38 4.50 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales n/m 4.68 8.98
Earnings yield (9.30%) (7.54%) (34.89%)
Free cash flow yield (7.98%) (7.77%) (24.52%)

Profitability

Metric PHVS ZLAB Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% (62.99%) 0.00%
Net margin 0.00% (44.91%) 0.00%
Free cash flow margin 0.00% (44.57%) 0.00%
Return on equity (71.50%) (29.99%) (50.12%)
Return on assets (64.43%) (18.18%) (45.60%)
Return on invested capital 0.00% (21.32%) 0.00%

Growth

Metric PHVS ZLAB Biotechnology median
Revenue growth (TTM) — 0.02% 6.26%
EPS growth (last fiscal year) (25.37%) 38.46% 29.88%
Revenue growth, 5-year CAGR — 56.54% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PHVS ZLAB Biotechnology median
Debt to equity 0.00 0.45 0.00
Current ratio 11.94 2.04 4.89
Net debt to EBITDA 1.72 2.66 1.01

Dividend

Metric PHVS ZLAB Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric PHVS ZLAB Biotechnology median
Market cap 2.28b 2.55b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack